HTD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 44.11 EUR 11.93% Market Closed

Market Cap: €3B

C	Corcept Therapeutics Inc SWB:HTD	US
M	Microstrategy Inc F:MIGA	US
H	Haulotte Group SA XBER:PHT	FR

Profitability Summary

Corcept Therapeutics Inc's profitability score is 54/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Negative Operating Margin

-1%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

23% > -1%

Low Net Margin

Sustainable 3Y Average Net Margin

19%

Declining Net Margin

22% > 6%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

25%

Declining Free Cash Flow Margin

31% > 16%

Low ROE

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

36%

Declining ROIC

63% > -7%

View All

Hide

Collapse

54 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.